LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE

Rhea-AI Summary

Lazard (NYSE: LAZ) announced two senior hires: John Koski and Rob Lowe joined as Managing Directors in the Healthcare Group in New York on Feb 18, 2026.

Both join from Allen & Co. and will advise across healthcare services, strengthening Lazard's advisory capacity amid evolving policy, capital markets, and technology shifts.

News Market Reaction – LAZ

+0.54%

2 alerts

+0.54% Session close to close

$5.22B Market Cap

0.0x Rel. Volume

In the Feb 18 session, LAZ gained 0.54%, reflecting a mild positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement adds two senior Managing Directors to Lazard’s Healthcare Group, reinforcing its s...

Analysis

This announcement adds two senior Managing Directors to Lazard’s Healthcare Group, reinforcing its strategy of building sector-focused advisory depth in healthcare services. It follows recent milestones including record $1.8B adjusted Financial Advisory revenue in 2025, AUM of $266.95B as of January 2026, and a quarterly dividend of $0.50 per share. Investors may watch for subsequent transaction mandates, revenue contribution from healthcare, and any additional leadership or compensation disclosures in future earnings releases and 8-K filings.

Historical Context

5 past events · Latest: Feb 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 10	AUM update	Positive	-0.1%	Reported January 2026 AUM of $266.95B with market and FX appreciation.
Jan 29	CFO appointment	Neutral	+2.2%	Named Tracy Farr as CFO effective Feb 1, 2026, succeeding prior CFO.
Jan 29	Earnings results	Positive	+2.2%	Reported Q4 and full-year 2025 results with record advisory revenue and higher AUM.
Jan 28	Dividend declaration	Neutral	-0.3%	Declared quarterly dividend of $0.50 per share with set record and pay dates.
Jan 22	Fund distribution	Neutral	-3.3%	LGI fund announced monthly distribution with high return-of-capital component.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news and earnings generally saw price reactions aligned with the underlying news tone, with only one mild divergence on an AUM update.

Recent Company History

Over the last month, Lazard has focused on financial performance, capital returns, and leadership. It reported Q4 and full-year 2025 results with full-year net revenue of $3,099M and record $1.8B adjusted Financial Advisory revenue, alongside AUM rising to $254B. A quarterly dividend of $0.50 per share was declared, and Tracy Farr was appointed CFO effective February 1, 2026. The January 2026 AUM update showed $266.95B, with net inflows and market gains. Today’s expansion of the Healthcare Services team fits this ongoing growth and leadership build-out narrative.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today announced that John Koski and Rob Lowe joined the firm in New York as Managing Directors in the Healthcare Group, advising on transactions across the healthcare services sector. These appointments underscore Lazard's continued investment in its Healthcare Group and focus on providing thoughtful, high-quality strategic advice to executives, boards, and investors across the healthcare sector. This announcement also reflects the ongoing momentum behind Lazard's long-term growth strategy, as exceptional bankers are increasingly drawn to the firm's entrepreneurial culture, renowned brand, and global platform. 

"John and Rob are exceptional advisors with deep sector expertise, a proven track record as thoughtful strategic advisors, and trusted client relationships," said David Gluckman, Global Head of Healthcare at Lazard. "Across the rapidly evolving healthcare services ecosystem, leadership teams, boards and investors face increasing complexity from evolving healthcare policy, dynamic macroeconomic and capital markets conditions, innovative payment models and technological transformation. The addition of John and Rob to our team will further enhance our ability to deliver high-impact, strategic and financial advice, helping our clients to seize opportunities and navigate this changing competitive landscape." 

Prior to joining Lazard, John served as Managing Director at Allen & Co. where he advised healthcare companies across the healthcare services sector, including payors, providers, distributors, and companies at the intersection of healthcare and technology. Earlier in his career, he was a Resident in Orthopedic Surgery at the Hospital for Special Surgery. John holds an MBA from Harvard Business School, an MD from the Yale School of Medicine, and a BA in Biology from Harvard University. 

"I am excited to join Lazard's Healthcare team, a platform known for its deep sector expertise and commitment to delivering thoughtful, high‑impact advice. The firm's entrepreneurial culture and global reach create a compelling opportunity to support clients as they navigate a rapidly evolving healthcare landscape," said John Koski.  

Rob also joins Lazard from Allen & Co., where he was a Managing Director, advising on transactions across healthcare, including payors, providers, distributors, and companies at the intersection of healthcare and technology. Previously, Rob served as a Director in Healthcare at Citi as part of the Global Healthcare Investment Banking Group. He earned his MBA from NYU Stern and his bachelor's degree from Colgate University. 

"Lazard's Healthcare franchise offers a unique combination of strategic insight, client focus, and a highly collaborative environment. I am thrilled to join this team and help build on its strong momentum, partnering with clients to capitalize on growth opportunities and address today's dynamic healthcare ecosystem," said Rob Lowe.  

About Lazard  

Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Lazard is listed on the New York Stock Exchange as Lazard, Inc. under the ticker LAZ. For more information, please visit Lazard.com and follow Lazard on LinkedIn. 

Investor Relations
 Alexandra Deignan
+1 212-632-6886
alexandra.deignan@lazard.com

Media Relations
Jessica Francisco
+1 212-632-6571
jessica.francisco@lazard.com                                     

Shannon Houston
+1 212-632-6880
shannon.houston@lazard.com                                     

View original content to download multimedia:https://www.prnewswire.com/news-releases/lazard-expands-its-healthcare-services-team-with-addition-of-john-koski-and-robert-lowe-302691391.html

SOURCE Lazard

FAQ

Who are John Koski and Rob Lowe and when did they join Lazard (LAZ)?

They are Managing Directors who joined Lazard's Healthcare Group on Feb 18, 2026. According to the company, both joined in New York from Allen & Co. to advise on transactions across the healthcare services sector and expand Lazard's advisory capabilities.

What experience do the new Lazard (LAZ) hires bring to the Healthcare Group?

Both bring senior healthcare investment banking experience, including roles advising payors, providers, and health-tech companies. According to the company, Koski and Lowe previously served as Managing Directors at Allen & Co., and Lowe earlier worked in healthcare at Citi.

How might the appointments of Koski and Lowe affect Lazard's (LAZ) healthcare advisory capabilities?

The hires are expected to strengthen Lazard's strategic and transaction advisory depth in healthcare services. According to the company, their sector expertise and client relationships will enhance the firm's ability to advise executives, boards, and investors on complex deals.

What are John Koski's academic and professional credentials noted by Lazard (LAZ)?

Koski holds an MD from Yale, an MBA from Harvard Business School, and a BA in Biology from Harvard. According to the company, he previously was a Resident in Orthopedic Surgery and later a Managing Director advising healthcare clients at Allen & Co.

Where will Koski and Lowe be based and what sectors will they cover for Lazard (LAZ)?

They will be based in New York and will advise across the healthcare services sector. According to the company, their coverage includes payors, providers, distributors, and companies at the intersection of healthcare and technology.